X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Strides Arcolab with Abbott India - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STRIDES SHASUN LTD vs ABBOTT INDIA - Comparison Results

STRIDES SHASUN LTD    Change

Strides Arcolab is an Indian pharmaceutical company headquartered at Bangalore. The company is primarily involved in two businesses notably the pharma business and the specialized sterile products business branded as Agila. This segment focuses large... More

ABBOTT INDIA 
   Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STRIDES SHASUN LTD ABBOTT INDIA STRIDES SHASUN LTD/
ABBOTT INDIA
 
P/E (TTM) x 13.9 32.3 42.9% View Chart
P/BV x 1.9 8.1 23.2% View Chart
Dividend Yield % 0.6 0.8 66.8%  

Financials

 STRIDES SHASUN LTD   ABBOTT INDIA
EQUITY SHARE DATA
    STRIDES SHASUN LTD
Mar-16
ABBOTT INDIA
Mar-16
STRIDES SHASUN LTD/
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs1,4136,015 23.5%   
Low Rs8483,707 22.9%   
Sales per share (Unadj.) Rs353.31,236.9 28.6%  
Earnings per share (Unadj.) Rs23.4122.2 19.1%  
Cash flow per share (Unadj.) Rs41.0129.0 31.8%  
Dividends per share (Unadj.) Rs5.0035.00 14.3%  
Dividend yield (eoy) %0.40.7 61.4%  
Book value per share (Unadj.) Rs320.4521.2 61.5%  
Shares outstanding (eoy) m89.3521.25 420.5%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x3.23.9 81.4%   
Avg P/E ratio x48.339.8 121.5%  
P/CF ratio (eoy) x27.637.7 73.2%  
Price / Book Value ratio x3.59.3 37.8%  
Dividend payout %21.428.6 74.6%   
Avg Mkt Cap Rs m100,988103,296 97.8%   
No. of employees `0004.73.0 158.7%   
Total wages/salary Rs m4,9883,370 148.0%   
Avg. sales/employee Rs Th6,730.08,891.8 75.7%   
Avg. wages/employee Rs Th1,063.61,140.0 93.3%   
Avg. net profit/employee Rs Th445.5878.3 50.7%   
INCOME DATA
Net Sales Rs m31,56426,284 120.1%  
Other income Rs m1,212504 240.3%   
Total revenues Rs m32,77626,789 122.3%   
Gross profit Rs m5,2133,665 142.2%  
Depreciation Rs m1,573144 1,089.2%   
Interest Rs m1,8038 22,260.5%   
Profit before tax Rs m3,0494,017 75.9%   
Minority Interest Rs m1270-   
Prior Period Items Rs m-270-   
Extraordinary Inc (Exp) Rs m-3710-   
Tax Rs m6891,421 48.5%   
Profit after tax Rs m2,0892,596 80.5%  
Gross profit margin %16.513.9 118.4%  
Effective tax rate %22.635.4 63.8%   
Net profit margin %6.69.9 67.0%  
BALANCE SHEET DATA
Current assets Rs m35,94914,446 248.8%   
Current liabilities Rs m19,4024,725 410.6%   
Net working cap to sales %52.437.0 141.7%  
Current ratio x1.93.1 60.6%  
Inventory Days Days7151 138.0%  
Debtors Days Days12720 648.3%  
Net fixed assets Rs m34,4781,113 3,098.0%   
Share capital Rs m894213 420.5%   
"Free" reserves Rs m22,60110,808 209.1%   
Net worth Rs m28,63211,076 258.5%   
Long term debt Rs m27,4550-   
Total assets Rs m76,59116,241 471.6%  
Interest coverage x2.7497.0 0.5%   
Debt to equity ratio x1.00-  
Sales to assets ratio x0.41.6 25.5%   
Return on assets %5.116.0 31.7%  
Return on equity %7.323.4 31.1%  
Return on capital %8.236.3 22.5%  
Exports to sales %48.10.6 7,828.7%   
Imports to sales %14.512.6 114.4%   
Exports (fob) Rs m15,192162 9,401.2%   
Imports (cif) Rs m4,5653,322 137.4%   
Fx inflow Rs m16,612268 6,198.5%   
Fx outflow Rs m5,2923,927 134.7%   
Net fx Rs m11,320-3,659 -309.3%   
CASH FLOW
From Operations Rs m7172,514 28.5%  
From Investments Rs m-22,284-800 2,787.3%  
From Financial Activity Rs m29,488-803 -3,672.6%  
Net Cashflow Rs m8,073912 885.3%  

Share Holding

Indian Promoters % 27.7 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 37.8 7.9 478.5%  
FIIs % 8.6 0.1 8,600.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.9 17.1 151.5%  
Shareholders   56,241 18,270 307.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STRIDES SHASUN LTD With:   DIVIS LABORATORIES  WOCKHARDT LTD.  VENUS REMEDIES  PANACEA BIOTECH  GLENMARK PHARMA  

Compare STRIDES SHASUN LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Post Noon Sell-Off; Infosys Falls 5.4%(Closing)

Share markets in India witnessed a sharp fall in the final minutes of trade. At the closing bell, the BSE Sensex closed lower by 266 points. While, the NSE Nifty finished lower by 83 points.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Profitable Investment in the History of the World(Vivek Kaul's Diary)

Aug 8, 2017

'Yes, it looks like a bubble. And, yes, it's like buying a lottery ticket. But there's something happening that has never happened before. It's an evolutionary leap in money itself.'

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STRIDES SHASUN LTD SHARE PRICE


Aug 21, 2017 (Close)

TRACK STRIDES SHASUN LTD

  • Track your investment in STRIDES SHASUN LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STRIDES SHASUN LTD

STRIDES SHASUN LTD - J.B.CHEMICALS COMPARISON

COMPARE STRIDES SHASUN LTD WITH

MARKET STATS